Schedule of Accrued Expenses and Other Current Liabilities (Details) - Sonnet BioTherapeutics Holdings, Inc. [Member] - USD ($) |
Jun. 30, 2025 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|---|---|---|---|
| Compensation and benefits | $ 168,281 | $ 149,802 | $ 2,091,196 |
| Research and development | 777,846 | 617,545 | 913,145 |
| Professional fees | 334,821 | 173,319 | 224,031 |
| Other | 1,958 | 1,823 | 2,550 |
| Accrued expenses and other current liabilities | $ 1,282,906 | $ 942,489 | $ 3,230,922 |